DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 2, 2026.

DVA is advancing kidney care through IKC expansion, CMS CKCC progress and AI-driven dialysis schedul

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2026.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

In the most recent trading session, DaVita HealthCare (DVA) closed at $217.04, indicating a +1.72% s

Analysts don't like to put "sell" ratings on S&P 500 stocks. So the fact they're willing to do it wi

LYB, HRB and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 26th, 2026.

TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and raises the price targe

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Top Wall Street analysts upgraded several top stocks. See all changes and ratings on Benzinga's

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised

Deutsche Bank analyst Pito Chickering upgrades DaVita (NYSE:DVA) from Hold to Buy and raises the

DaVita (NYSE:DVA) reported quarterly earnings of $2.87 per share which beat the analyst consensus es

The latest 13F filing from Berkshire Hathaway reveals some of the final position changes made by War

Wall Street extended losses into midday trading Tuesday as geopolitical tensions in the Middle East

DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 gu

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price

DaVita (NYSE:DVA) reported quarterly earnings of $3.40 per share which beat the analyst consensus es

Warren Buffett's Berkshire Hathaway took a new stake in a member of the Magnificent Seven, while

TD Cowen analyst Ryan Langston maintains DaVita (NYSE:DVA) with a Hold and lowers the price targe

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price

DaVita (NYSE:DVA) reported quarterly earnings of $2.51 per share which missed the analyst consensus

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price

B of A Securities analyst Kevin Fischbeck maintains DaVita (NYSE:DVA) with a Underperform and low

DaVita reported a ransomware attack affecting 2.7 million patients, posted Q2 earnings above estimat

A look at the updated Berkshire Hathaway portfolio after the second quarter, including a new stake i

Warren Buffett has requested confidentiality in a new Berkshire Hathaway position. Will investors fi

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and lowers the price

U.S. stock futures jumped on Monday after a muted day of trade on Friday. Futures of benchmark indic

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent d

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% i

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings

The markets exhibited a mixed trend Monday, with technology heavyweights experienced a slight downtu